Protein interaction data curation: the International Molecular Exchange (IMEx) consortium. by Orchard, S. et al.
  
Serveur Académique Lausannois SERVAL serval.unil.ch 
Author Manuscript 
Faculty of Biology and Medicine Publication 
This paper has been peer-reviewed but dos not include the final publisher 
proof-corrections or journal pagination. 
Published in final edited form as:  
 
In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains 
an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article. 
 
Title: Protein interaction data curation: the International Molecular 
Exchange (IMEx) consortium. 
Authors: Orchard S, Kerrien S, Abbani S, Aranda B, Bhate J, Bidwell S, 
Bridge A, Briganti L, Brinkman FS, Cesareni G, Chatr-aryamontri A, 
Chautard E, Chen C, Dumousseau M, Goll J, Hancock RE, Hannick LI, 
Jurisica I, Khadake J, Lynn DJ, Mahadevan U, Perfetto L, Raghunath A, 
Ricard-Blum S, Roechert B, Salwinski L, Stümpflen V, Tyers M, Uetz P, 
Xenarios I, Hermjakob H 
Journal: Nature methods 
Year: 2012 Apr 
Volume: 9 
Issue: 4 
Pages: 345-50 
DOI: 10.1038/nmeth.1931 
 
Protein Interaction Data Curation - The International Molecular
Exchange Consortium (IMEx)
Sandra Orchard1, Samuel Kerrien1, Sara Abbani2, Bruno Aranda1, Jignesh Bhate3, Shelby
Bidwell4, Alan Bridge5, Leonardo Briganti6, Fiona S. L. Brinkman7, Gianni Cesareni6,8,
Andrew Chatr-aryamontri6,9, Emilie Chautard10,11, Carol Chen12, Marine Dumousseau1,
Johannes Goll4, Robert E. W. Hancock12, Linda I. Hannick4, Igor Jurisica13, Jyoti
Khadake1, David J. Lynn14, Usha Mahadevan3, Livia Perfetto6, Arathi Raghunath3, Sylvie
Ricard-Blum11, Bernd Roechert5, Lukasz Salwinski2, Volker Stümpflen15, Mike Tyers9,16,
Peter Uetz17,18, Ioannis Xenarios5,19,20, and Henning Hermjakob1
1European Molecular Biology Laboratory – European Bioinformatics Institute, Wellcome Trust
Genome Campus, Hinxton CB10 1SD, UK 2University of California, Los Angeles Department of
Energy Institute for Genomics and Proteomics, Los Angeles, California, USA 3Molecular
Connections Pvt. Ltd., Kandala Mansions, 2/2 Kariappa Road, Basavangudi, Bangalore - 560004,
India 4The J. Craig Venter Institute, Rockville, MD 20850, USA 5Swiss-Prot group, SIB Swiss
Institute of Bioinformatics, CMU 1, Rue Michel Servet, 1211 Geneva 4 6Department of Biology,
University of Rome Tor Vergata, Via della Ricerca Scientifica, Rome Italy 7Department of
Molecular Biology and Biochemistry, 8888 University Drive, Simon Fraser University, Burnaby,
British Columbia, Canada, V5A 1S6 8Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)-
Fondazione S. Lucia, Rome, Italy 9Wellcome Trust Centre for Cell Biology, School of Biological
Sciences, University of Edinburgh, Mayfield Road, Edinburgh, Scotland 10Institut de Biologie et
Chimie des Protéines, UMR 5086 CNRS – Université Lyon 1, IFR 128 Biosciences Gerland Lyon
Sud, 7 passage du Vercors, 69367 Lyon Cedex 07, France 11Ontario Institute for Cancer
Research, MaRS Centre, South Tower, 101 College Street, Suite 800, Toronto, Ontario, Canada,
M5G 0A3 12Centre for Microbial Diseases and Immunity Research, 232 - 2259 Lower Mall,
University of British Columbia, Vancouver, British Columbia, Canada, V6T 1Z4 13Ontario Cancer
Institute, the Campbell Family Institute for Cancer Research, and Techna Institute, University
Health Network, 101 College Street, Toronto, Ontario M5G 1L7, Canada 14Animal & Bioscience
Research Department, AGRIC, Teagasc, Grange, Dunsany, Co. Meath, Ireland 15Helmholtz
Zentrum München - German Research Center for Environmental Health, Institute of
Bioinformatics and Systems Biology (MIPS), Neuherberg, Germany 16Samuel Lunenfeld
Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada 17Proteros Biostructures,
Martinsried, Germany 18Center for the Study of Biological Complexity, Virginia Commonwealth
University, Richmond, VA, USA 19Vital-IT group, SIB Swiss Institute of Bioinformatics, Quartier
Sorge, Bâtiment Génopode, 1015 Lausanne, Switzerland 20University of Lausanne, Quartier
Sorge, Bâtiment Génopode, 1015 Lausanne, Switzerland
Abstract
The IMEx consortium is an international collaboration between major public interaction data
providers to share curation effort and make a non-redundant set of protein interactions available in
a single search interface on a common website (www.imexconsortium.org). Common curation
rules have been developed and a central registry is used to manage the selection of articles to enter
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into the dataset. The advantages of such a service to the user, quality control measures adopted
and data distribution practices are discussed.
Introduction
Protein-protein interactions are a key element in our understanding of molecular biology.
However, in contrast to areas of activity such as DNA sequencing or protein structural
analysis, the systematic capture of published molecular interaction data into public domain
repositories is still in its infancy. This is not due to lack of resources in this domain. As of
December 2011, the PathGuide resource [1] listed more than 100 protein-protein interaction
(PPI) –related databases. Although many of these focus on predictions of potential
interactions or interologue-mapping, rather than experimentally determined interactions, the
level of activity suggests ample resources. However, most of these resources are
independently funded and pursue their goals in isolation. As a result, accessing all publicly
available molecular interaction data, even on a specific biological or biomedical topic, is a
challenging, time-consuming task requiring the user to query multiple resources, each with a
different interface, many using different identifiers and often containing redundant data from
overlapping sets of publications.
Efforts to address this problem began ten years ago with the development of a common file
format for representing protein interaction data. The Minimum Information about a
Molecular Interaction eXperiment (MIMIX) guidelines were then published [2] defining a
checklist of the information to be supplied when describing experimental molecular
interaction data in a journal article. In parallel to this, the curation strategies of a select
group of molecular interaction databases, the IMEx Consortium, were coordinated to create
a single non-redundant set of homogeneously curated protein interaction data, as discussed
in this article.
A Common Data Format and the IMEx Consortium
The issue of the individual data resource formats maintained by the separate resources has
largely been addressed by the efforts of the Human Proteome Organisation Proteomics
Standards Initiative (HUPO-PSI) [3]. In 2002, a number of protein interaction data
providers, among them BIND [4], DIP [5], Hybrigenics [6], IntAct [7], MINT [8], and MIPS
[9], set out to develop a common file format for the representation of protein interaction
data. This resulted in the creation of the HUPO PSI-MI XML format [10], which is now
widely implemented, and has since been expanded to enable the interchange of all forms of
molecular interaction data [11]. This enables the user to download, combine, visualize and
analyze data in a single format from multiple resources. It has since been supplemented by a
simplified tabular format, MITAB [11].
While a common data format is a key step in providing consistent, user-friendly access to
publicly available molecular interaction data, it is only a first stage. Until recently, all
interaction databases independently curated interaction data publications, on occasion
resulting in several alternative datasets derived from a single publication, due to the
implementation of different curation strategies. In addition to the use of scarce public
funding for the duplication of expensive manual database curation, the differences in the
datasets can leave the user bewildered about which to regard as the correct interpretation of
the data within the paper. To address this issue, five molecular interaction databases agreed
in September 2005 on a long-term co-ordination of their curation strategies. The framework
for this collaboration was the International Molecular Exchange Consortium (IMEx) which
currently comprises DIP [5], IntAct [7], MatrixDB [12], MINT [8], MPIDB [13], I2D [14],
InnateDB [15] and Molecular Connections (www.molecularconnections.com) as full
Orchard et al. Page 2
Nat Methods. Author manuscript; available in PMC 2013 July 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
members, with BioGRID [16] as an observer member. A full IMEx member commits to
producing a relevant number of records curated to a common IMEx standard whereas an
observer member is a prospective IMEx consortium member working with the full members
to produce the curation rules and improve curation quality. The aims of IMEx are to
coordinate curation to avoid redundant work on the same data, increase curation coverage
and synchronize curation strategies to ensure consistency of data across all IMEx member
databases. Since 2005 an increasing number of these databases have been working together
to generate a single set of curation rules to ensure both the quality and consistency of
annotation across the IMEx databases. As a result of many detailed IMEx consortium
discussions, a single joint IMEx curation manual (www.imexconsortium.org/curation) has
been agreed upon and made publicly available. This forms the basis for the curation by all
IMEx partner databases and at all levels uses the controlled vocabularies developed by the
HUPO-PSI [10,11].
Curation strategy and coverage
Currently interaction databases contain a considerable amount of redundant data, i.e. the
same paper curated by multiple resources, often to differing depths of curation or following
different annotation strategies. As stated above, one of the major aims of the IMEx
Consortium is to present the user with a non-redundant set of data to search, namely each
paper should be present only once in the IMEx set, with the protein-protein interaction
information it contains having been fully captured following a consistent set of rules.
Initially, the IMEx databases agreed to share the curation workload based on journal
selection. Each IMEx database selected one or more journals to curate, with the aim of
representing all relevant protein-protein interaction data published in that journal in the
database within a reasonably short time frame, normally less than three months from
publication. The journal(s) were selected by the databases and largely reflect their particular
areas of interest or editorial connections. Table 1 shows the current IMEx journal coverage.
There is no pre-selection of data from particular organisms, although, in practice, the well-
studied model organisms such as human, mouse, Arabidopsis, Saccharomyces cerevisiae
and E. coli also tend to be the best represented in the scientific literature available for
curation.
Whilst articles from targeted journals form the baseline of IMEx curation, most databases
curate additional publications, the choice usually based on scientific collaborations, curator
expertise, or to reflect the specialization of thematic databases such as MatrixDB and
MPIDB. As an example, IntAct recently curated a targeted dataset on interactions of
proteins that play a role in Alzheimer’s Disease [17]. Until recently, these targeted curation
efforts were not coordinated between the IMEx members. However, in 2010 we released
IMExCentral, a web service which enables IMEx partners to reserve any publication for
curation, either manually through a web interface, or through a web service directly from
our curation tools. Based on this tool, we are now also coordinating curation of all individual
publications outside of the journal curation commitment.
IMEx members are currently working on releasing a non-redundant set of all papers curated
to IMEx standards by the participating databases since 2006. Key large-scale papers, such as
the Giot protein interaction map of Drosophila melanogaster [18], and the Rual [19] and
Stelzl [20] human protein-protein interaction networks have been recurated to the existing
IMEx standard and released to the dataset. More recent large-scale papers are routinely
added to the dataset and users are encouraged to propose additional publications for
curation.
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Several of the participating databases contain data curated to different depths (see below) or
which were curated during the period whilst the IMEx rules were under development. As
can be seen in Table 2, the majority of the participating databases still have a wealth of
curated papers which have yet to be released to the IMEx dataset. A major aim of 2012 will
be to identify archival papers appropriate for release through the IMEx website and, if
necessary, re-curate these to current IMEx standards. Papers curated by MINT and IntAct as
training and test datasets for the BioCreative competitions [21,22] have already been
released as part of this process. Where a paper has previously been redundantly curated, i.e.
it has been annotated by more than one IMEx database, IMExCentral will only allow one
copy of the paper to acquire an IMEx accession number and will alert the databases if a
second resource attempts to register the same publication.
IMExCentral already allows participating databases to encourage and manage the annotation
of directly submitted data as an integral part of the publication process. Authors may submit
data to any IMEx database. A common identifier allocated by IMExCentral (IM-xxxx), will
allow data users to access the dataset, subsequent to publication, both in the original
resource and via the IMEx website. Should identical data be offered to more than one
member database, this will immediately be highlighted by the IMExCentral service when a
database attempts to register a second copy of the same dataset.
In addition to deposition of new experimental data, IMEx users can also request curation of
specific publications via the IMEx web site (http://www.imexconsortium.org), for example
if they notice a well-known interaction missing from the IMEx databases or to establish the
currently know interactions for a particular research target.
Curation depth
The IMEx partners have committed to a "deep" curation model, which aims to capture the
full experimental detail provided in the interaction report, as this is often essential to assess
interaction context and confidence. In fact, it has become increasingly clear that minor
changes in experimental detail may have dramatic effects on the outcome of an interaction
experiment [23]. Fig. 1a shows a breakdown of the major interaction detection methods used
to identify protein interactions represented within the IMEx dataset, as defined in the PSI-
MI controlled vocabulary (www.ebi.ac.uk/ontology-lookup/browse.do?ontName=MI).
IMEx members refer to all interactions between two molecules as binary interactions and
these are classified by the type of binding described (Fig.1b). ‘Association’ indicates that the
interaction is from an experimental method which identifies a loose co-complex, within
which all the members may not have been identified, typically by co-immunoprecipitation or
pulldown from an in vivo sample. ‘Physical association’ indicates the interaction has been
identified by a method indicating a tighter complex, but again in which all the members may
not have been identified, for example protein complementation assays such as yeast 2-
hybrid. ‘Direct interaction’ indicates that the two molecules are known to be in actual
physical contact with each other. Such data is only taken from in vitro methodologies and
does not include yeast 2-hybrid assays, but we acknowledge that when performed properly
yeast 2-hybrid assays are strong evidence of a direct interaction. Experimental molecular
features such as affinity tags, labels, and functional protein modifications including post-
processing of the transcript or phosphorylation sites are mapped to the given sequence, as
are binding domains and interacting residues. Author-provided confidence scores are also
documented, where this data is available. Where essential data as required by the MIMIx
guidelines [2] are not available, we aim to obtain the data from the corresponding author, or
mark the manuscript as containing data that cannot be annotated. The IMEx Consortium
collates experimental evidences from any species for which interaction data is available
(Fig. 1c).
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Quality control
Curation rules are only useful if they are consistently applied, and the IMEx consortium is
gradually implementing measures for mutual quality control. The PSI validator [24], a tool
which executes a set of rules based on the PSI-MI ontology to check XML files, provides
not only syntactic checking of released files, but also semantic checking, validating the use
of the correct controlled vocabularies as well as more complex, context-dependent rules. A
set of validator rules ensuring compliance with the IMEx curation manual have been
developed and are now publicly available for use by consortium members, data submitters
and, indeed, any user of the PSI-MI XML format.
Cross-curation exercises have been undertaken, and will remain an ongoing regular exercise,
with a number of ‘challenging’ papers being selected for annotation by all participating
databases. The resulting download files are compared and issues discussed to ensure
curation rules and controlled vocabularies are used consistently across databases.
Alternatively, rules/vocabularies may be modified to address challenging issues.
In addition, each month, one database selects a paper for discussion by the collaboration,
initially via a Wiki page, but if problems cannot be resolved, then they can be discussed in
person by phone conference or face-to-face meetings. In this way, rules can be generated to
address new technologies or variations on accepted methodologies. Finally, approximately
20 papers highlighted by the iRefIndex database [25] as being curated by more than one
IMEx database have been compared. The redundant curation predated the formation of
IMEx and the exercise confirmed that the current IMEx curation rules and internal quality
control measures would have addressed the vast majority of problems identified.
Data dissemination
Many collaborative curation projects, for example UniProt, Gene Ontology annotation, or
wwPDB, exchange data on a regular basis, with the data from each partner being copied to
all other partners. However, the regular full copying of complex records from multiple
partners, and in particular the management of the updates and deletions of both interaction
records and the underlying sequences to which they are mapped, is highly resource-
consuming in terms of both computational load and staff. While the IMEx partners have
been increasingly collaborating since 2005, we only recently entered IMEx ‘production
mode’ with the regular release of IMEx records and requiring sharing of curated interaction
data between partners.
Recently, a standard interface for direct computational access to standards-compliant
molecular interaction data resources, the PSI Common Query Interface (PSICQUIC) was
developed [26]. PSICQUIC supports simultaneous querying of multiple participating
molecular interaction databases.
The IMEx partners decided to use the distributed PSICQUIC system as the basis for IMEx
data dissemination to minimize the data exchange overhead [26]. Delivery of the IMEx set
of interaction records to the IMEx partners and individual member database websites is done
through a tagging process. Only IMEx partners may use the IMEx tag and only records
presented in a registered PSICQUIC service tagged as an IMEx record and with an IMEx
accession number will be part of this IMEx dataset. Each IMEx partner operates a
PSICQUIC server, and a PSICQUIC client can query all partners for IMEx data matching a
given query, providing an up-to-date view of all relevant data from all IMEx partners.
Because the PSICQUIC service can query data from non-IMEx as well as IMEx members,
uses can access either the tagged IMEx subset or all of the available interaction data.
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However, when searching across the entirety of data available through PSICQUIC, it is
currently difficult to separate out experimentally proven binary pairs from predicted
interactions, functional associations or the results from text-mining. This data is also highly
redundant, in that the manually curated data in primary databases is re-exported by several
integrative databases such as iRefIndex [25], APID [27] and STRING [28]. Unfortunately,
much of the experimental detail may be lost during the integration process although a link
back to the primary database record is usually provided. For example, at the time of going to
press, PMID:17923092 appeared in 5 resources when searched for in PSICQUIC, and in
many of these resources, it is not clear that the majority of data in this paper derives from
genetic interference assays (MI:0254) as the data in integrative databases can lack the
detailed information required to make this clear. In the IMEx set, each interaction
publication appears once only, with experimental detail and the protein constructs clearly
defined. Users are encouraged to access and search the IMEx dataset via PSICQUIC, either
directly on the website (www.imexconsortium.org) or via member database websites.
In addition to the interactive PSICQUIC access, all IMEx data is also available for full
download in PSI-MI XML or MITAB tabular formats. All IMEx data from all partners is
freely available without any restrictions.
In the future, we expect a significant increase in the coverage of IMEx records, in particular
through ongoing curation, and the acquisition of new IMEx partners, but also through the
"upgrade" of existing archival records to IMEx records as discussed above. In particular, we
will validate and where necessary re-curate widely used large scale interaction data sets as
IMEx records. Most importantly, however, we aim to shift the focus of IMEx curation from
the curation of manuscripts after publication, to pre-publication, in collaboration with all
relevant stakeholders. The curation of data prior to publication, in a direct dialog with the
authors, ensures a data representation that is both factually correct, and optimally aligned
with the authors' view of the data. Through inclusion of IMEx accession numbers in the
publication, and data release synchronized with the publication of the manuscript, both
parties benefit from increased visibility, and users benefit from timely access to this
comprehensive, annotated and accurate protein interaction data.
Why is the IMEx Consortium necessary?
As previously stated, a significant number of interaction databases exist, which attempt to
capture PPI data from the literature using different curation strategies. In addition to this,
there are now a number of ‘composite’ databases, which contribute no novel manual
curation but instead merge the work of other resources. Other databases take a median
strategy and import selected data from curated resources whilst adding to this by their own
annotation efforts. There are also datasets of predicted protein interactions, using a variety of
information sources. Attempts to merge data are often frustrated by the differing strategies
adopted by the databases, in particular when mapping ambiguous protein descriptions given
in the text to identifiers in sequence databases. Even when both gene name and species are
stated, which is often not the case [2], authors rarely clearly define which isoform of the
protein they are dealing with, even when this information is known. Databases deal with this
ambiguity in several ways, either by mapping to a gene identifier and sacrificing all ability
to map to a specific isoform (BioGrid) or by selecting one transcript, usually the longest
(BIND), which makes it impossible to indicate when this is an ambiguous or a specific
mapping, or by utilizing the canonical sequence displayed by UniProtKB (IntAct, MINT,
DIP, MatrixDB, I2D, MPIDB).
A further cause of apparent differences between databases is caused by their varying policies
to describe interactions demonstrated between protein constructs from different species e.g.
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human-mouse. Most databases report the data as performed by in the experiment, others
choose to model this onto a single organism, for example human (HPRD) [29]. Additionally,
databases may only partially curate a publication, extracting only content which relates to
their specific area of interest (InnateDB, HPRD, MPIDB). Whilst none of these policies are
in any way wrong, they do create difficulties when attempting to reconcile redundancies
between databases. A recent report suggested agreement between databases may be only
54% for curated interactions and 71% in protein identifications and attributed much of this
to the difficulties described above [30]. The effect of curation errors cannot be ignored but a
recent re-curation exercise showed this to range from 2–9% for a number of different
databases [31].
The authors firmly believe that the policy followed by the IMEx Consortium of taking a
coordinated, collaborative rather than competing approach to the intergation of protein-
protein interaction data provides the best possible service to the user community. We not
only achieve a much broader coverage of the interaction literature published in each
calendar year than a single database working in isolation can achieve, but we also provide
the research community with a single point of access to the data, removing the need to
combine records from different databases. The quality control measures, both internal and
cross-database, being developed by the consortium minimize curation error, and by
supplying data consistently mapped to external reference resources, eliminate errors
potentially introduced when identifiers are remapped by third-party resources.
The IMEx records are mapped to the UniProtKB canonical sequence [32] when the isoform
is ambiguous, and to the specific isoform identifier when known, with the corresponding
entity in RefSeq [33], mapped at the sequence level, also referenced. To facilitate
coordination among resources, we use a scientific publication as the basic unit of IMEx
curation. If a publication is curated within IMEx, it is curated in full, harvesting all reported
protein-protein interactions into the database, rather than, for example, only those relevant
for a specific disease. This enables full data traceability and where possible, we provide
even more fine-grained data source information, by annotating figure or supplement
numbers from which the data have been extracted. The quality control measures currently
being implemented will also act to bring down the curation error rates cited above and
improve data quality. Turinsky et al. concluded that “Many of the discrepancies we
identified should in the future be eliminated if the IMEx guidelines are widely followed.”
[30]
Outlook
We believe that by establishing a network of closely collaborating interaction data resources
with a common data representation, query interface, and shared curation rules, we are
creating a novel, reliable and highly visible infrastructure for protein interaction data
collection that will motivate data producers, funding agencies and journals to increasingly
make interaction data deposition an integral part of the publication process. Enforcing
quality control checks across the partner databases will improve data quality, and clear
statements of our curation policies will make these transparent to users, and ensure
consistency across the entire IMEx dataset. Regular meetings enable the review of these
curation rules and will allow us to rapidly respond to new data types such as quantitative
data and dynamic interactions. The IMEx consortium is open to the participation of new
partners, and all data producers are encouraged to submit their data to one of the IMEx
partners prior to publication. For detailed information on IMEx membership and data
deposition, please see http://www.imexconsortium.org.
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Figure 1. Overview of the IMEx dataset
(a) Interaction detection methods currently represented in the IMEx dataset.
(b) Types of interaction data represented in the IMEx dataset.
(c) The range of species for which data is available in the IMEx dataset.
Data taken from December 2011
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Table 1
Current journal coverage by IMEx members
Journal Name Period of Coverage Database
Cancer Cell 01/2006– present IntAct
Cell 01/2006– present IntAct
FEBS Letters 01/2005– present MINT
EMBO Journal 01/2006– present MINT
EMBO Reports 01/2006– present MINT
J. Bacteriology 08/2007–present MPIDB
J. Molecular Signalling 11/2006–present Molecular Connections
Matrix Biology 01/2009–present MatrixDB
Molecular Cancer 09/2010–present Molecular Connections
Molecular Microbiology 08/2007–08/2009 MPIDB
Nature Immunology 10/2010 – present InnateDB
Nature Structural and Molecular Biology 01/2006–present DIP
Oncogene 09/2010 I2D
PLoS Biology 01/2003–present DIP
Proteomics 01/2005–present IntAct
Structure 01/2006–present DIP
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